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Figure. A draining lesion in his left inguinal region with 
surrounding induration and cellulitis extending onto his perineum 
with enlarged, edematous scrotum.
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A 51-year-old male with hepatitis C and a history of 
intravenous (IV) drug use presented to the emergency 
department, reporting one day of worsening scrotal pain 
and swelling. He denied diabetes, trauma, or infection 
with HIV. His genitourinary examination revealed a 
draining lesion in his left inguinal region with surrounding 
induration and cellulitis extending onto his perineum. 
His scrotum was enlarged, edematous, and tender with 
a distinct region of ecchymosis (Figure). A calculated 
Laboratory Risk Indicator for Necrotizing Fasciitis 
(LRINEC) score was 7, indicating a moderate risk for 
necrotizing soft tissue infection (NSTI).1 Shortly after 
arrival, the patient was transferred to the operating room 
for surgical debridement, where the diagnosis of Fournier’s 
gangrene was confirmed. 
Fournier gangrene is a rapidly-spreading NSTI of 
the perineum causing fascial and subcutaneous tissue 
destruction, with mortality rates of 17% to 34%.2 Risk 
factors for NSTIs and Fournier gangrene include diabetes, 
IV drug use, trauma, recent surgery, immune suppression 
(e.g., cirrhosis or malignancy), peripheral vascular disease, 
and morbid obesity.2,3 Fournier gangrene is classically 
associated with eccymotic changes, edema, erythema, and 
drainage from wounds. These findings, however, tend to 
Table. Laboratory Risk Indicator for Necrotizing Fasciitis Score
Variable Value Points
C-Reactive Protien (mg/L) < 150 0
> 150 4
WBC (cells/mm3) < 15 0
15-25 1
> 25 2
Hemoglobin (g/dL) > 13.5 0
11-13.5 1
< 11 2
Serum sodium (mmol/L) > 135 0
< 135 2
Serum creatinine (mg/dL) < 1.6 0
> 1.6 2
Plasma glucose (mg/dL) < 180 0
> 180 2
Risk Probability Total Score
Low < 50% < 5
Moderate 50-75% 6-7
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arise late in the disease process. Early indicators that must 
heighten a clinician’s suspicion include severe genital pain 
and tenderness in the absence of external signs. 
Multiple laboratory markers have been suggested as 
useful in diagnosing NSTIs.1,4 The LRINEC score (See 
Table) is a weighted point system of such markers often 
used to stratify patients into low, moderate, or high risk for 
NSTIs.1
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